Markus Rudin
Markus Rudin has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Diana Baumann
Central Technologes, Novartis Pharma AG, Basel, Switzerland
2 shared publicationsMartin Rausch
Discovery Technologies and
2 shared publicationsRobert Pórszász
Central Technologes, Novartis Pharma AG, Basel, Switzerland
2 shared publicationsTorsten Reese
Central Technologes, Novartis Pharma AG, Basel, Switzerland
2 shared publicationsAndre Sauter
Nervous System, Novartis Pharma AG, Basel, Switzerland
1 shared publicationAndré Sauter
Nervous System Therapeutic Area, Novartis Pharma Ltd, CH‐4002 Basel, Switzerland
1 shared publication
Latest Publications
- 15 July 2004
- Published by Wiley in European Journal of Neuroscience
- Vol. 20 (3) , 811-817
Restricted diffusion in the brain of transgenic mice with cerebral amyloidosis
A prominent hallmark of Alzheimer's disease pathology is cerebral amyloidosis. However, it is not clear how extracellular amyloid‐β peptide (Aβ) deposition and amyloid formation compromise brain function and lead to dementia. It has been argued that extracellular amyloid deposition is neurotoxic and/or that soluble Aβ oligomers impair synaptic function. Amyloid deposits, by contrast, may affect diffusion properties of the brain interstitium with implications for the transport of endogenous signalling molecules during synaptic and/or extrasynaptic transmission. We have used diffusion‐weighted magnetic resonance imaging to study diffusion properties in brains of young (6‐month‐old) and aged (25‐month‐old) APP23 transgenic mice and control littermates. Our results demonstrate that fibrillar amyloid deposits and associated gliosis in brains of aged APP23 transgenic mice are accompanied by a reduction in the apparent diffusion coefficient. This decrease was most pronounced in neocortical areas with a high percentage of congophilic amyloid and was not significant in the caudate putamen, an area with only modest and diffuse amyloid deposition. These findings suggest that extracellular deposition of fibrillar amyloid and/or associated glial proliferation and hypertrophy cause restrictions to interstitial fluid diffusion. Reduced diffusivity within the interstitial space may alter volume transmission and therefore contribute to the cognitive impairment in Alzheimer's disease.
- 15 July 2004
- Published by Wiley in European Journal of Neuroscience
- Vol. 20 (3) , 811-817
Restricted diffusion in the brain of transgenic mice with cerebral amyloidosis
A prominent hallmark of Alzheimer's disease pathology is cerebral amyloidosis. However, it is not clear how extracellular amyloid‐β peptide (Aβ) deposition and amyloid formation compromise brain function and lead to dementia. It has been argued that extracellular amyloid deposition is neurotoxic and/or that soluble Aβ oligomers impair synaptic function. Amyloid deposits, by contrast, may affect diffusion properties of the brain interstitium with implications for the transport of endogenous signalling molecules during synaptic and/or extrasynaptic transmission. We have used diffusion‐weighted magnetic resonance imaging to study diffusion properties in brains of young (6‐month‐old) and aged (25‐month‐old) APP23 transgenic mice and control littermates. Our results demonstrate that fibrillar amyloid deposits and associated gliosis in brains of aged APP23 transgenic mice are accompanied by a reduction in the apparent diffusion coefficient. This decrease was most pronounced in neocortical areas with a high percentage of congophilic amyloid and was not significant in the caudate putamen, an area with only modest and diffuse amyloid deposition. These findings suggest that extracellular deposition of fibrillar amyloid and/or associated glial proliferation and hypertrophy cause restrictions to interstitial fluid diffusion. Reduced diffusivity within the interstitial space may alter volume transmission and therefore contribute to the cognitive impairment in Alzheimer's disease.
- 28 March 2002
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 47 (4) , 759-765
Recovery of function in cytoprotected cerebral cortex in rat stroke model assessed by functional MRI
Functional recovery in cytoprotected somatosensory cortex in a rat stroke model was studied using functional MRI (fMRI). Calcium antagonist treatment (isradipine) following permanent middle cerebral artery occlusion (pMCAO) reduced the infarct volume by 33 ± 9%. The somatosensory cortex representing the forepaws was spared from infarction; however, cerebral blood flow (CBF) was significantly reduced in this area 24 hr following pMCAO. Neural function was assessed at days 1, 2, 5, and 12 following pMCAO by fMRI using electrical stimulation of both forepaws. Vehicle‐treated rats did not show fMRI responses in the infarcted somatosensory cortex throughout the study. Several of the isradipine‐treated animals displayed functional recovery in the cytoprotected cortex at days 5 (3/5 rats) and 12 (5/10). Correlations with fMRI signals showed that normal T2 and ADC values in the respective brain areas are necessary, but not sufficient prerequisites for functionality. Recovery of neural function is associated with normalization of CBF in the cytoprotected brain area. Magn Reson Med 47:759–765, 2002.
- 28 March 2002
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 47 (4) , 759-765
Recovery of function in cytoprotected cerebral cortex in rat stroke model assessed by functional MRI
Functional recovery in cytoprotected somatosensory cortex in a rat stroke model was studied using functional MRI (fMRI). Calcium antagonist treatment (isradipine) following permanent middle cerebral artery occlusion (pMCAO) reduced the infarct volume by 33 ± 9%. The somatosensory cortex representing the forepaws was spared from infarction; however, cerebral blood flow (CBF) was significantly reduced in this area 24 hr following pMCAO. Neural function was assessed at days 1, 2, 5, and 12 following pMCAO by fMRI using electrical stimulation of both forepaws. Vehicle‐treated rats did not show fMRI responses in the infarcted somatosensory cortex throughout the study. Several of the isradipine‐treated animals displayed functional recovery in the cytoprotected cortex at days 5 (3/5 rats) and 12 (5/10). Correlations with fMRI signals showed that normal T2 and ADC values in the respective brain areas are necessary, but not sufficient prerequisites for functionality. Recovery of neural function is associated with normalization of CBF in the cytoprotected brain area. Magn Reson Med 47:759–765, 2002.
- 14 September 2000
- Published by Wiley in NMR in Biomedicine
- Vol. 13 (6) , 361-370
Cytoprotection does not preserve brain functionality in rats during the acute post-stroke phase despite evidence of non-infarction provided by MRI
In animal models of stroke the promise of a therapy is commonly judged from infarct size measurements, assuming that a reduction in infarct size results in reduction of the functional deficits. We have evaluated the validity of the concept that structural integrity translates into functional integrity during the acute post‐stroke period (24 h). Unilateral permanent middle cerebral artery occlusion (pMCAO) in Fischer F344 rats leads to infarcts comprising the ipsilateral striatum and cortical structures, including the somatosensory cortex. Infarct volumes were assessed using magnetic resonance imaging (MRI) methods (T2, diffusion, perfusion MRI). The functional integrity of the somatosensory cortex was assessed by functional MRI (fMRI) measuring changes in local cerebral blood volume, and by assessing the forelimb grip strength and the beam‐walking performance of the animals. Treatment with the calcium antagonist isradipine (2.5 mg/kg injected s.c. immediately after pMCAO) reduced the total infarct size by more than 40% compared to vehicle‐injected controls. In particular, the ipsilateral somatosensory cortex appeared normal in diffusion‐ and T2‐weighted MRI images. In sham‐operated rats simultaneous electrical stimulation of both forepaws led to similar activation of both somatosensory cortices, while in pMCAO animals given vehicle only the contralateral cortex showed an fMRI response. Similarly, in pMCAO rats treated with isradipine, functional activation following bilateral electrical stimulation was only detected in the contralateral somatosensory cortex despite the normal appearance of the ipsilateral cortex in MRI images. Furthermore, fMRI responses to pharmacological stimulation with bicuculline were virtually absent in the ipsilateral somatosensory cortices both in vehicle‐ and isradipine‐treated rats. Finally there was no significant difference between vehicle‐ and isradipine‐treated animals upon the performance of beam‐walking test or in forelimb grip strength. It is concluded that during the acute (24 h) post‐occlusion period, structural integrity in the somatosensory cortex revealed by MRI does not translate into preservation of function. Copyright © 2000 John Wiley & Sons, Ltd. Abbreviations used: ADC apparent diffusion coefficient ATP adenosine triphosphate BOLD blood oxygen level dependent CBF cerebral blood flow CBV cerebral blood volume DW diffusion weighted FOV field‐of‐view fMRI functional magnetic resonance imaging MRI magnetic resonance imaging NA number of averages PET positron emission tomography pMCAO permanent middle cerebral artery occlusion RARE rapid acquisition with relaxation enhancement s.c. subcutaneously SW spectral width TE echo delay TR repetition delay T2W T2‐weighted.
- 14 September 2000
- Published by Wiley in NMR in Biomedicine
- Vol. 13 (6) , 361-370
Cytoprotection does not preserve brain functionality in rats during the acute post-stroke phase despite evidence of non-infarction provided by MRI
In animal models of stroke the promise of a therapy is commonly judged from infarct size measurements, assuming that a reduction in infarct size results in reduction of the functional deficits. We have evaluated the validity of the concept that structural integrity translates into functional integrity during the acute post‐stroke period (24 h). Unilateral permanent middle cerebral artery occlusion (pMCAO) in Fischer F344 rats leads to infarcts comprising the ipsilateral striatum and cortical structures, including the somatosensory cortex. Infarct volumes were assessed using magnetic resonance imaging (MRI) methods (T2, diffusion, perfusion MRI). The functional integrity of the somatosensory cortex was assessed by functional MRI (fMRI) measuring changes in local cerebral blood volume, and by assessing the forelimb grip strength and the beam‐walking performance of the animals. Treatment with the calcium antagonist isradipine (2.5 mg/kg injected s.c. immediately after pMCAO) reduced the total infarct size by more than 40% compared to vehicle‐injected controls. In particular, the ipsilateral somatosensory cortex appeared normal in diffusion‐ and T2‐weighted MRI images. In sham‐operated rats simultaneous electrical stimulation of both forepaws led to similar activation of both somatosensory cortices, while in pMCAO animals given vehicle only the contralateral cortex showed an fMRI response. Similarly, in pMCAO rats treated with isradipine, functional activation following bilateral electrical stimulation was only detected in the contralateral somatosensory cortex despite the normal appearance of the ipsilateral cortex in MRI images. Furthermore, fMRI responses to pharmacological stimulation with bicuculline were virtually absent in the ipsilateral somatosensory cortices both in vehicle‐ and isradipine‐treated rats. Finally there was no significant difference between vehicle‐ and isradipine‐treated animals upon the performance of beam‐walking test or in forelimb grip strength. It is concluded that during the acute (24 h) post‐occlusion period, structural integrity in the somatosensory cortex revealed by MRI does not translate into preservation of function. Copyright © 2000 John Wiley & Sons, Ltd. Abbreviations used: ADC apparent diffusion coefficient ATP adenosine triphosphate BOLD blood oxygen level dependent CBF cerebral blood flow CBV cerebral blood volume DW diffusion weighted FOV field‐of‐view fMRI functional magnetic resonance imaging MRI magnetic resonance imaging NA number of averages PET positron emission tomography pMCAO permanent middle cerebral artery occlusion RARE rapid acquisition with relaxation enhancement s.c. subcutaneously SW spectral width TE echo delay TR repetition delay T2W T2‐weighted.